Inhibition of LpxC Increases the Activity of Iron Chelators and Gallium Nitrate in Multidrug-Resistant Acinetobacter baumannii

被引:5
作者
Vinuesa, Victor [1 ]
Cruces, Raquel [1 ]
Nonnoi, Francesca [1 ]
McConnell, Michael J. [2 ]
机构
[1] Inst Salud Carlos III, Natl Ctr Microbiol, Intrahospital Infect Lab, Madrid 28220, Spain
[2] Vaxdyn SL, Ave Manuel Siurot S-N, Seville 41010, Spain
来源
ANTIBIOTICS-BASEL | 2021年 / 10卷 / 05期
关键词
LpxC inhibitors; iron chelators; gallium; antibiotic resistance; synergy; IN-VITRO; ANTIMICROBIAL AGENTS; COLISTIN RESISTANCE; LIPOPOLYSACCHARIDE; SUSCEPTIBILITY;
D O I
10.3390/antibiotics10050609
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Infections caused by multidrug-resistant Acinetobacter baumannii would benefit from the development of novel treatment approaches. Compounds that interfere with bacterial iron metabolism, such as iron chelators and gallium nitrate, have previously been shown to have antimicrobial activity against A. baumannii. In this study, we characterize the effect of LpxC inhibitors on the antimicrobial activity of previously characterized iron chelators, 2,2 '-bipyridyl (BIP) and deferiprone (DFP), and gallium nitrate (Ga(NO3)(3)) against A. baumannii reference strains and multidrug-resistant clinical isolates. The LpxC inhibitor LpxC-2 was synergistic with BIP for 30% of strains tested (FICI values: 0.38-1.02), whereas inhibition with LpxC-4 was synergistic with BIP for 60% of strains tested (FICI values: 0.09-0.75). In time-kill assays, combinations of BIP with both LpxC inhibitors demonstrated synergistic activity, with a more than 3 log(10) reduction in bacterial counts compared to BIP alone. LpxC-2 was synergistic with Ga(NO3)(3) for 50% of strains tested (FICI values: 0.27-1.0), whereas LpxC-4 was synergistic with Ga(NO3)(3) for all strains tested (FICI values: 0.08-<= 0.50). In time-kill assays, combinations of Ga(NO3)(3) with LpxC-2 and LpxC-4 decreased the growth of both strains compared to each compound separately; however, only the combination with LpxC-4 met the defined criteria for synergy. These results identify a novel synergy between two antimicrobial classes against A. baumannii strains.
引用
收藏
页数:8
相关论文
共 20 条
[1]   In Vitro and In Vivo Antimicrobial Activities of Gallium Nitrate against Multidrug-Resistant Acinetobacter baumannii [J].
Antunes, Luisa C. S. ;
Imperi, Francesco ;
Minandri, Fabrizia ;
Visca, Paolo .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2012, 56 (11) :5961-5970
[2]  
Bernstein LR, 1998, PHARMACOL REV, V50, P665
[3]   Phenotypic changes associated with Colistin resistance due to Lipopolysaccharide loss in Acinetobacter baumannii [J].
Carretero-Ledesma, Marta ;
Garcia-Quintanilla, Meritxell ;
Martin-Pena, Reyes ;
Pulido, Marina R. ;
Pachon, Jeronimo ;
McConnell, Michael J. .
VIRULENCE, 2018, 9 (01) :930-942
[4]   Dual Inhibition of Klebsiella pneumoniae and Pseudomonas aeruginosa Iron Metabolism Using Gallium Porphyrin and Gallium Nitrate [J].
Choi, Seoung-ryoung ;
Britigan, Bradley E. ;
Narayanasamy, Prabagaran .
ACS INFECTIOUS DISEASES, 2019, 5 (09) :1559-1569
[5]   Clonal diversity and antimicrobial susceptibility of Acinetobacter baumannii isolated in Spain.: A nationwide study:: GEIH-Ab project (2000) [J].
Fernández-Cuenca, F ;
Pascual, A ;
Ribera, A ;
Vila, J ;
Bou, G ;
Cisneros, JM ;
Rodríguez-Baño, J ;
Pachón, J ;
Marítinez-Martínez, L .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2004, 22 (05) :267-271
[6]   In vitro activity of 18 antimicrobial agents against clinical isolates of Acinetobacter spp.: multicenter national study GEIH-REIPI-Ab 2010 [J].
Fernandez-Cuenca, Felipe ;
Tomas-Carmona, Maria ;
Caballero-Moyano, Francisco ;
Bou, German ;
Martinez-Martinez, Luis ;
Vila, Jordi ;
Pachon, Jeronimo ;
Miguel Cisneros, Jose ;
Rodriguez-Bano, Jesus ;
Pascual, Alvaro .
ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2013, 31 (01) :4-9
[7]   Inhibition of LpxC Increases Antibiotic Susceptibility in Acinetobacter baumannii [J].
Garcia-Quintanilla, Meritxell ;
Caro-Vega, Jose M. ;
Pulido, Marina R. ;
Moreno-Martinez, Patricia ;
Pachon, Jeronimo ;
McConnell, Michael J. .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2016, 60 (08) :5076-5079
[8]   Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections [J].
Goss, Christopher H. ;
Kaneko, Yukihiro ;
Khuu, Lisa ;
Anderson, Gail D. ;
Ravishankar, Sumedha ;
Aitken, Moira L. ;
Lechtzin, Noah ;
Zhou, Guolin ;
Czyz, Daniel M. ;
McLean, Kathryn ;
Olakanmi, Oyebode ;
Shuman, Howard A. ;
Teresi, Mary ;
Wilhelm, Ellen ;
Caldwell, Ellen ;
Salipante, Stephen J. ;
Hornick, Douglas B. ;
Siehnel, Richard J. ;
Becker, Lev ;
Britigan, Bradley E. ;
Singh, Pradeep K. .
SCIENCE TRANSLATIONAL MEDICINE, 2018, 10 (460)
[9]   Antimicrobial Activity of Gallium Compounds on ESKAPE Pathogens [J].
Hijazi, Sarah ;
Visaggio, Daniela ;
Pirolo, Mattia ;
Frangipani, Emanuela ;
Bernstein, Lawrence ;
Visca, Paolo .
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2018, 8
[10]   Inhibition of LpxC Protects Mice from Resistant Acinetobacter baumannii by Modulating Inflammation and Enhancing Phagocytosis [J].
Lin, Lin ;
Tan, Brandon ;
Pantapalangkoor, Paul ;
Ho, Tiffany ;
Baquir, Beverlie ;
Tomaras, Andrew ;
Montgomery, Justin I. ;
Reilly, Usa ;
Barbacci, Elsa G. ;
Hujer, Kristine ;
Bonomo, Robert A. ;
Fernandez, Lucia ;
Hancock, Robert E. W. ;
Adams, Mark D. ;
French, Samuel W. ;
Buslon, Virgil S. ;
Spellberg, Brad .
MBIO, 2012, 3 (05)